The extrapancreatic effects of glucagon-like peptide-1 and related peptides
Dysgeusia refers to a distortion or alteration in the sense of taste, which has been reported by some patients taking Wegovy (semaglutide 2.4 mg)
Pavlides S, Whitaker-Menezes D, Castello-Cros R, Flomenberg N, Witkiewicz AK, Frank PG, Casimiro MC, Wang C, Fortina P, Addya S, Pestell RG, Martinez-Outschoorn UE, Sotgia F, Lisanti MP (2009) The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma
Routine supplementation with selenium is not recommended, and iodine supplements should be avoided in autoimmune thyroiditis
Common Cigna Coverage Barriers for GLP-1 Therapy Cigna frequently requires documented BMI over 30 kg/m plus at least one weight-related condition (diabetes, hypertension, sleep apnea) to justify semaglutide coverage
Above a certain point, additional B6 provides no further benefit and begins to carry toxicity risk